U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07059169) titled 'CAR-T Therapy for Refractory Autoimmune Diseases' on July 01.
Brief Summary: This study is an investigator-initiated single center, single arm clinical study with a target population of patients with refractory autoimmune diseases. It is an early exploratory clinical study of the safety, tolerability and initial efficacy of CD19 CAR-T in the treatment of refractory autoimmune diseases.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Autoimmune Diseases
Intervention:
DRUG: JY231 (JY231 injection)
JY231 injection is administered intravenously and produces autologous CAR-T cells in the patient's body some time...